Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Keratosis, Actinic 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Warts 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Radiodermatitis 1 Parapsoriasis 1 Non-Melanoma Skin Cancer (NMSC) 1 Neoplasms 1 Hypogonadism 1 Hemangioma, Cavernous 1 Hemangioma 1 Head and Neck Cancer Patients Treated With Radiotherapy 1 Fatigue 1 Exanthema 1 Eunuchism 1 Dermatitis, Contact 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Carcinoma 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Cisplatin 21 pembrolizumab 16 Gemcitabine 16 Paclitaxel 15 Radiotherapy 14 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Cyclophosphamide 9 Cetuximab 9 Magnetic Resonance Spectroscopy 8 Radiation 7 padeliporfin 6 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Drug Therapy 6 Docetaxel 6 Capecitabine 6 Bevacizumab 6 anlotinib 5 Nivolumab 5 Irinotecan 5 Erlotinib Hydrochloride 5 Celecoxib 5 poly ICLC 4 fludarabine 4 Standard of Care 4 Sorafenib 4 Leucovorin 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Gels × Clear all

NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡